Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Journal of Cancer Research and Clinical Oncology|July 1, 2018
FOXM1 predicts disease progression in non-muscle invasive bladder cancerSebastien Rinaldetti, Ralph Wirtz, Thomas Stefan Worst, et al.Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|April 7, 2021
Factors to improve academic publishing success of physicians engaged in scientific researchManuel Neuberger, Christel Weiß, Thomas Stefan Worst, et al.Cancers|November 27, 2019
ANLN and TLE2 in Muscle Invasive Bladder Cancer: A Functional and Clinical Evaluation Based on In Silico and In Vitro DataSheng Wu, Katja Nitschke, Jakob Heinkele, et al.Scientific Reports|November 25, 2020
Subtype specific expression and survival prediction of pivotal lncRNAs in muscle invasive bladder cancerSebastien Rinaldetti, Thomas Stefan Worst, Eugen Rempel, et al.World Journal of Urology|June 14, 2020
Treatment decision satisfaction and regret after focal HIFU for localized prostate cancerNiklas Westhoff, Ramona Ernst, Karl Friedrich Kowalewski, et al.Oncotarget|June 15, 2018
Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screeningSebastien Rinaldetti, Eugen Rempel, Thomas Stefan Worst, et al.Journal of Experimental & Clinical Cancer Research : CR|December 18, 2020
Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancerSheng Wu, Katja Nitschke, Thomas Stefan Worst, et al.Urologia Internationalis|July 13, 2017
Oncologic Response and Hospitalization Rate of Patients Receiving Cabazitaxel in the Fourth-Line and Beyond in Castration-Resistant Prostate Cancer: Analysis of a Retrospective Cohort and a Structured Literature ReviewJost von Hardenberg, Maike Schwartz, Thorsten Werner, et al.Discover Oncology|August 27, 2024
Optimized workflow of EV enrichment from human plasma samples for downstream mass spectrometry analysisPatrick Erwied, Yi Gu, Lena Simon, et al.Clinical Genitourinary Cancer|February 3, 2019
Programmed Death Ligand 1 (PD-L1) Status and Tumor-Infiltrating Lymphocytes in Hot Spots of Primary and Liver Metastases in Prostate Cancer With Neuroendocrine DifferentiationJost von Hardenberg, Sarah Hartmann, Katja Nitschke, et al.Pageof 4